Planning and evaluation is an active process at the Ohio State University Comprehensive Cancer Center. A University-based long range plan is being developed and carried out by a renowned management consulting firm, Deloitte and Touche. The planning effort culminated in a retreat of the Project Steering Committee which identified the key issues for a five year plan. The strategic plan for the CCC-CHRI resulted from this planning process. The key areas of the plan are research, patient care, education, organization and management, human and financial resources. The External Advisory Committee (EAC) is composed of Dr. Carlo Croce, Dr. C. Russell de Burlo, Dr. Richard Rifkind, Dr. Thomas R. Tritton, Dr. Frederick Valeriote, Dr. Daniel Van Hoff and Dr. Ernst L. Wynder. This distinguished group meets annually to discuss planning, management of programs, and administration. The Committee reports directly to Dr. Schuller but meets also with Center Senior Leaders and University officials during its annual site visit. The Internal Advisory Committee (IAC) consists of Deans of the various Colleges in which the OSUCCC Programs are conducted. This committee, which is chaired by the Associate Vice President for Health Services, Dr. Ronald L. St. Pierre, meets three times yearly. The CCC-member advisory committees include the Committees for Space Allocation, Basic Research, Clinical Research, Community Research, Research Development Award Committee, and Clinical Scientific Review Committee.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA016058-21
Application #
3729042
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
21
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Ohio State University
Department
Type
DUNS #
098987217
City
Columbus
State
OH
Country
United States
Zip Code
43210
Neff, Robert; Rush, Craig M; Smith, Blair et al. (2018) Functional characterization of recurrent FOXA2 mutations seen in endometrial cancers. Int J Cancer 143:2955-2961
Comiskey Jr, D F; Jacob, A G; Sanford, B L et al. (2018) A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo. Oncogene 37:95-106
Dietrich, Sascha; Ole?, Ma?gorzata; Lu, Junyan et al. (2018) Drug-perturbation-based stratification of blood cancer. J Clin Invest 128:427-445
Chen, Zhong; Wu, Dayong; Thomas-Ahner, Jennifer M et al. (2018) Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13. Proc Natl Acad Sci U S A 115:6810-6815
Moshiri, Farzaneh; Salvi, Alessandro; Gramantieri, Laura et al. (2018) Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma. Oncotarget 9:15350-15364
Petrov, Brawnie; Aldoori, Ayat; James, Cindy et al. (2018) Bipolar disorder in youth is associated with increased levels of vitamin D-binding protein. Transl Psychiatry 8:61
Senaras, Caglar; Niazi, Muhammad Khalid Khan; Sahiner, Berkman et al. (2018) Optimized generation of high-resolution phantom images using cGAN: Application to quantification of Ki67 breast cancer images. PLoS One 13:e0196846
Kovac, Rachel L; Ballash, Gregory; Fenger, Joelle et al. (2018) Plasma cytokeratin-18 concentrations as noninvasive biomarker of early gastrointestinal toxicosis in dogs receiving toceranib. J Vet Intern Med 32:2061-2068
Locke, Landon W; Kothandaraman, Shankaran; Tweedle, Michael et al. (2018) Use of a leukocyte-targeted peptide probe as a potential tracer for imaging the tuberculosis granuloma. Tuberculosis (Edinb) 108:201-210
Yi, Long; Chen, Luxi; Guo, Xiaofeng et al. (2018) A Synthetic Disaccharide Derivative of Diphyllin, TAARD, Activates Human Natural Killer Cells to Secrete Interferon-Gamma via Toll-Like Receptor-Mediated NF-?B and STAT3 Signaling Pathways. Front Immunol 9:1509

Showing the most recent 10 out of 2602 publications